Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (721-730 of 858) with videos related to

Pageof 86
Sort By:
European Urology Oncology|January 25, 2026
Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & EvaluationRiccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al.
BJU International|September 22, 2022
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostateEkaterina Laukhtina, Marco Moschini, Wojciech Krajewski, et al.
World Journal of Urology|July 27, 2020
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intentStefania Zamboni, Luca Afferi, Francesco Soria, et al.
Cancers|October 16, 2025
Local Recurrence After Nephron Surgery: What to Do? An Italian Multicentric RegistryAngelo Porreca, Filippo Marino, Davide De Marchi, et al.
European Urology Oncology|January 1, 2021
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
Current Urology|April 21, 2025
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers in ItalyGiorgio Mazzon, Stefania Ferretti, Emanuele Serafin, et al.
European Urology Open Science|March 6, 2023
The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing SurgeryCarlo Andrea Bravi, Giuseppe Rosiello, Elio Mazzone, et al.
Therapeutic Advances in Urology|August 5, 2025
Artificial intelligence and radiomics applications in adrenal lesions: a systematic reviewMatteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, et al.
Urologic Oncology|October 25, 2023
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysisCesare Saitta, Jonathan A Afari, Riccardo Autorino, et al.
Pageof 86

Showing results (721-730 of 858) with videos related to

Sort By:
Pageof 86
European Urology Oncology|January 25, 2026
Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & EvaluationRiccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al.
BJU International|September 22, 2022
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostateEkaterina Laukhtina, Marco Moschini, Wojciech Krajewski, et al.
World Journal of Urology|July 27, 2020
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intentStefania Zamboni, Luca Afferi, Francesco Soria, et al.
Cancers|October 16, 2025
Local Recurrence After Nephron Surgery: What to Do? An Italian Multicentric RegistryAngelo Porreca, Filippo Marino, Davide De Marchi, et al.
European Urology Oncology|January 1, 2021
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)Michele Marchioni, Maximilian Kriegmair, Mathias Heck, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
Current Urology|April 21, 2025
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers in ItalyGiorgio Mazzon, Stefania Ferretti, Emanuele Serafin, et al.
European Urology Open Science|March 6, 2023
The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing SurgeryCarlo Andrea Bravi, Giuseppe Rosiello, Elio Mazzone, et al.
Therapeutic Advances in Urology|August 5, 2025
Artificial intelligence and radiomics applications in adrenal lesions: a systematic reviewMatteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, et al.
Urologic Oncology|October 25, 2023
Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysisCesare Saitta, Jonathan A Afari, Riccardo Autorino, et al.
Pageof 86